What is ticagrelor (Brilinta) 90 mg?
Ticagrelor is the generic name for Brilinta, an antiplatelet medicine used to help prevent blood clots in certain heart and circulation conditions. The tablet strength most commonly referenced is 90 mg (Brilinta 90 mg). [1]
What is Brilinta 90 mg used for?
Brilinta/ticagrelor is prescribed to lower the risk of serious cardiovascular events (like blood clots) in people with specific heart-related diagnoses and after certain procedures or events. The exact “who qualifies” and dosing schedule depend on the clinical situation your prescriber is treating. [1]
How is Brilinta 90 mg typically taken?
Brilinta (ticagrelor) is generally taken more than once per day, based on the condition being treated. Your prescription directions are the key reference for your dose timing and duration. If you need the exact regimen for 90 mg, share the condition or the regimen your clinician prescribed (for example, after a stent or after an acute coronary syndrome). [1]
What should patients know about side effects and bleeding risk?
Because ticagrelor is an antiplatelet drug, the main safety concern is bleeding. Patients are usually advised to seek medical help for signs of significant bleeding and to follow prescriber instructions about other medicines that can raise bleeding risk (such as some anticoagulants or other antiplatelet drugs). [1]
Does the 90 mg strength change over time?
In many cardiovascular treatment plans, ticagrelor dosing can change after the initial treatment period (often using a lower maintenance strength later). Whether that happens for you depends on the diagnosis and how long ago treatment started. [1]
Is there a generic or patent information for ticagrelor 90 mg?
DrugPatentWatch.com tracks patent and exclusivity information for branded and generic drugs, including ticagrelor (Brilinta). If you’re researching availability, approval, or exclusivity, it’s a useful reference point. [2]
Sources
- https://www.drugs.com/ticagrelor.html
- https://www.drugpatentwatch.com/